Clinical Trial: Identification of New Markers in the Hypereosinophilic Syndrome

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional

Official Title: Identification of New Markers in the Hypereosinophilic Syndrome

Brief Summary: The purpose is to characterize new hypereosinophilic syndrome biomarkers more informative and more accessible compared to those that we have already thanks to a proteomic approach. This will help the investigators to diagnose the this disease.

Detailed Summary:
Sponsor: University Hospital, Lille

Current Primary Outcome: The aim is to characterize, through an approach immunoprotéomique, new HES biomarkers more informative and easier access than those currently available to us. These biomarkers will help to the diagnosis of HES, compared with other causes of eosinophilia. [ Time Frame: one month after patient inclusion ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University Hospital, Lille

Dates:
Date Received: October 22, 2012
Date Started: June 29, 2010
Date Completion: December 2018
Last Updated: May 17, 2017
Last Verified: May 2017